Durvalumab Intravenous and Insulin Degludec (U-100) Vials
Determining the interaction of Durvalumab Intravenous and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: durvalumab
Brand name: Imfinzi
Synonyms: Durvalumab
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Durvalumab Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Durvalumab Intravenous-Insulin degludec and liraglutide
- Durvalumab Intravenous-Insulin degludec and liraglutide Subcutaneous
- Durvalumab Intravenous-Insulin degludec Subcutaneous
- Durvalumab Intravenous-Insulin detemir
- Durvalumab Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Dutasteride
- Insulin Degludec (U-100) Vials-Dutasteride and tamsulosin
- Insulin Degludec (U-100) Vials-Dutasteride and Tamsulosin Capsules
- Insulin Degludec (U-100) Vials-Dutasteride Capsules
- Insulin Degludec (U-100) Vials-Dutoprol
- Insulin Degludec (U-100) Vials-Duvelisib